Merck news from FierceHealthcare
NewsSurprising facts about pharma's best paid pill-pushing docs
When doctors discuss what a medication can do, it confers a veneer of respectability on the drug company's marketing. But a ProPublica investigation uncovered that fewer than half of the best paid Read more...
Medical educators in Pennsylvania received at least $10 million from drug companies in 2009
Conflict-of-interest allegations aside, several Pittsburgh-area doctors and nurse educators are insisting that their work is not compromised despite data showing they were paid roughly $3.5 million Read more...
Glaxo stops funding commercial CME; Merck funding $150M non-profit vaccine developer;
> In another sign that drugmakers want to reduce their exposure to payola allegations, GlaxoSmithKline has announced that it will stop funding commercial continuing medical education programs. Read more...
Case study: Miami drug reps not registering as lobbyists
Right now, sentiment is high on Capitol Hill to expose the money flowing to doctors from pharmaceutical and medical device companies. A look at what's happening in some markets right now, however, Read more...
Wyeth faces whistleblower suits over Protonix pricing
In theory, drug companies are supposed to sell drugs to Medicaid for the lowest price that they offer commercial buyers. But according to two whistleblowers, Wyeth didn't follow the rules when it Read more...
Drugmakers offer performance-based pricing
Now here's an idea that is likely to win a lot of fans. Under pressure from insurance companies, pharmaceutical companies have begun to adjust what they charge for medications based on how well the Read more...
Baystate Medical subpeonaed for anesthesiologist's records
Federal investigators are now digging into the financial records of a Massachusetts anesthesiologist and former head of the acute pain unit at Baystate Medical Center in Springfield. Dr. Scott Reuben Read more...
MA anesthesiologist accused of fabricating 21 studies
While we at FierceHealthcare have covered all kinds of allegations regarding skulduggery in the research business, particularly questionable behavior that advances pharmaceutical company interests. Read more...
Pfizer will disclose payments to health professionals
Pfizer has announced that it plans to make data on payments to healthcare professionals publicly available starting in early 2010, including not only physicians, but also researchers and research Read more...
CVS Caremark accused of violating patient privacy
A few weeks ago we told you that the cost of diabetes care had skyrocketed in recent years. Now pharmaceutical benefits manager CVS Caremark is accused of doing their part to make the trend worse. Read more...
| Press ReleasesAHF Targets Merck Over AIDS Drug PricingAIDS group launches advocacy campaign pressuring the drug giant to heed President Obama’s call for drug companies to “do their part” to help Americans get access to life-saving AIDS treatments LOS Read more >> Strategic changes by big pharma accounted for 60% of partnership deal terminations between January 2010 and June 2011: com40% of pharmaceutical partnership deals terminated between January 2010 and June 2011 were valued at $400m-$600mStrategic changes are cited as the most common reason behind pharmaceutical deal Read more >> Merck Announces Fourth Quarter 2011 DividendWHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- At their meeting today, the Board of Directors of Merck (NYSE: MRK), known as MSD outside the United States and Canada, declared a quarterly dividend of Read more >> ImpactRx Names Kjell Nygren Vice President, Analytical ServicesCompany Announces Key Addition to Advanced Analytics TeamMOUNT LAUREL, N.J., June 21, 2011 /PRNewswire/ -- ImpactRx, the pioneer in measuring the impact of promotion on physician prescribing behavior Read more >> Merck to Present at Goldman Sachs 32nd Annual Healthcare ConferenceWHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Kenneth C. Frazier, Merck's president and chief executive Read more >> |
